Intellicell Biosciences Inc (fka SVFC)

[Traderboy1966]

IntelliCell's SVF stem cell technology used for basketball star, featured in NYDaily News
pm by Deborah Sterescu
IntelliCell BioScience (OTCQB:SVFC.PK) said Tuesday that its stromal vascular fraction (SVF) stem cell therapy was featured in an article in the New York Daily News over the weekend.
The company, through its proprietary technology, processes stromal vascular fraction (SVF) stem cells, derived from one's own body fat.
Fat stem cells are now the cutting edge, with many doctors and companies researching the use of them for anti-aging effects, as well as for the treatment of more serious conditions like arthritis, congestive heart failure, gum recession, and wound healing.
IntelliCell's SVF cells can be used to treat certain conditions, or rejuvinate damaged tissue and cell function. The company, which under the FDA is authorized to commercially sell its SVF cells, has also applied for a patent on its use of ultrasonic cavitations to break up fat cells, which increases the number of SVF stem cells that can be extracted from just two ounces of fat to between 500 million and 1.4 billion.
A full page Daily News article, titled “Stem Sells” written by Sean Brennan published February 19, 2012, http://www.nydailynews.com/sports/college/manhattan-basketball-torgrim-sommerfeldt-turned-stem-cell-treatment-back-court-article-1.1025227, describes how Torgrim Sommerfeldt’s budding basketball career was saved through Dr. Anthony Maddalo’s treatment using IntelliCell's proprietary SVF cell therapy.
Sommerfeldt, a former star player for the Norwegian National Basketball Team, had undergone six knee surgeries, and had forfeited his Wake Forest basketball scholarship.
However, Manhattan College took a chance on him and invited him to join their team.
In the article, Maddalo, Manhattan’s team doctor who is also the Rangers’ assistant team physician, was cited as saying: "He [Sommerfeldt] had exhausted almost every other conservative method we could possibly think of.
"He was bothered by chronic patellar tendinitis in both knees, and he had never really recovered from those operations (in Norway). He was in pain constantly. He couldn’t walk around campus without pain. We tried physical therapy, ultrasound, types of electric stimulation, exercise and stretching but nothing worked."
With limited options other than more surgery, Sommerfeldt and Maddalo decided to contact Dr. Steven Victor from Lenox Hill Hospital, who is also CEO of IntelliCell in New York City.
Due to the two IntelliCell SVF treatments in New York City by Dr. Maddalo near the end of 2010 and the beginning of 2011, Sommerfeldt started his first game for Manhattan College on January 20, 2012, "pain free", IntelliCell said.
CEO of IntelliCell BioSciences Victor, commented: "We are very proud that our proprietary technology used by Dr. Maddalo was able to rehabilitate Torgims’s knees and alleviate his pain.
"Sports related injuries are a predominate focus for our Company. Doctors using our proprietary technology have treated several professional and college athletes with excellent results. Patients have seen cartilage regrow in the knee.
"We are about to start a multi-center study for several sports injury indications at major centers. We are fortunate to have several top orthopedic surgeons on our advisory board such as; Dr. Andrews, Dr. Hackel, Dr. Dugas and Dr. Nicola.
"We believe the 2012–2013 years will see significant revenues from the use of our technology to treat athletes. We believe that this is a $1.3 billion market opportunity just in the United States."